Udo Gaipl

Head of Radiation Immunobiology

Universitätsklinikum Erlangen
Country flagGermany

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Udo Gaipl is the Head of Radiation Immunobiology at Universitätsklinikum Erlangen in Germany. His research focuses on the interactions between radiotherapy, immunotherapy, and tumor microenvironments, with recent publications addressing topics such as glioblastoma cell behavior under chemoradiation and the role of immune cells in tumor immunity. He is also actively engaged in developing novel therapeutic strategies, including radio-immunotherapies and nanoparticle applications in cancer treatment.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

We introduce a deep-learning- and a registration-based method for automatically analyzing the spatial distribution of nodal metastases (LNs) in head and neck (H/N) cancer cohorts to inform radiotherapy (RT) target volume design. The two methods are evaluated in a cohort of 193 H/N patients/planning CTs with a total of 449 LNs. In the deep learning method, a previously developed nnU-Net 3D/2D ensemble model is used to autosegment 20 H/N levels, with each LN subsequently being algorithmically assigned to the closest-level autosegmentation. In the nonrigid-registration-based mapping method, LNs are mapped into a calculated template CT representing the cohort-average patient anatomy, and kernel density estimation is employed to estimate the underlying average 3D-LN probability distribution allowing for analysis and visualization without prespecified level definitions. Multireader assessment by three radio-oncologists with majority voting was used to evaluate the deep learning method and obtain the ground-truth distribution. For the mapping technique, the proportion of LNs predicted by the 3D probability distribution for each level was calculated and compared to the deep learning and ground-truth distributions. As determined by a multireader review with majority voting, the deep learning method correctly categorized all 449 LNs to their respective levels. Level 2 showed the highest LN involvement (59.0%). The level involvement predicted by the mapping technique was consistent with the ground-truth distribution (p for difference 0.915). Application of the proposed methods to multicenter cohorts with selected H/N tumor subtypes for informing optimal RT target volume design is promising.

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (12)

Christoph Alexiou

Else Kröner Fresenius endowed W3 Professorship, Head of SEON

Universitätsklinikum Erlangen

GERMANY
View details

Franz Rödel

Goethe University Frankfurt

GERMANY
View details

Piotr Krzeczyński

Chief Specialist

Łukasiewicz Research Network - Industrial Chemistry Institute

POLAND
View details

Aleksander Bilewicz

Institute of Nuclear Chemistry and Technology

POLAND
View details

Aneta Rogalska

associate professor/PhD, DSc

Lodz University of Technology

POLAND
View details

Lukas Heger

-

GERMANY
View details

Florian Putz

University Hospital Erlangen

GERMANY
View details

Agnieszka Marczak

University of Łódź

POLAND
View details

Luitpold V. Distel

University Hospital Erlangen

GERMANY
View details

Maksim Ionov

Professor

Lodz University of Technology

POLAND
View details

Stephan Scheidegger

University of Applied Sciences

SWITZERLAND
View details

ALEXANDRE BARRAS

Institut d'Électronique de Microélectronique et de Nanotechnologie

FRANCE
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.